UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Information needs and research priorities in long‐term survivorship of breast cancer: Patients and health professionals' perspectives

European journal of cancer care, 2022-11, Vol.31 (6), p.e13730-n/a

2022

Volltextzugriff (PDF)

2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A451-A452

2022

Volltextzugriff (PDF)

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1584-1593

2016

Volltextzugriff (PDF)

Hypoglycemic Coma Secondary to Big Insulin‐like Growth Factor II Secretion by a Giant Phyllodes Tumor of the Breast

The breast journal, 2007-03, Vol.13 (2), p.189-191

2007

Volltextzugriff (PDF)

A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial—A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS5610-TPS5610

2018

Volltextzugriff (PDF)

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

European journal of endocrinology, 2017-10, Vol.177 (4), p.309-317

2017

Volltextzugriff (PDF)

Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone

Hematological oncology, 2014-09, Vol.32 (3), p.139-144

2014

Volltextzugriff (PDF)

Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma

Clinical & translational oncology, 2009-09, Vol.11 (9), p.604-608

2009

Volltextzugriff (PDF)

Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer

Journal of cancer research and clinical oncology, 2006-05, Vol.132 (5), p.332-338

2006

Volltextzugriff (PDF)

Soft tissue sarcomas: A challenge for oncology

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e21512-e21512

2014

Volltextzugriff (PDF)

Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene ( EGFR ) mutation testing

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19150-e19150

2014

Volltextzugriff (PDF)

Predictive serum biomarkers in metastatic colorectal cancer (mCRC) patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (BVZ) (GEMCAD 09-01)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14647-e14647

2015

Volltextzugriff (PDF)

Some unusual paraneoplastic syndromes. Case 1. Metastatic squamous cell esophageal cancer to the thumb

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2620-2620

2003

Volltextzugriff (PDF)

Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5549-5549

2021

Volltextzugriff (PDF)

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6027-6027

2014

Volltextzugriff (PDF)

False Elevation of Serum CA 15-3 Levels in Patients Under Follow-Up for Breast Cancer

The breast journal, 2004-07, Vol.10 (4), p.375-376

2004

Volltextzugriff (PDF)

Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors

Oncology research and treatment, 2018-01, Vol.41 (12), p.755-761

2018

Volltextzugriff (PDF)

Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma

Clinical lymphoma, myeloma and leukemia, 2015-12, Vol.15 (12), p.761-765

2015

Volltextzugriff (PDF)

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3589-3589

2013

Volltextzugriff (PDF)

Intensive Therapy for Aggressive Lymphoma/DR. MILPIED REPLIES

The New England journal of medicine, 2004-07, Vol.351 (1), p.98

2004

Volltextzugriff (PDF)

Therapeutic approaches in patients with newly diagnosed follicular lymphoma

Future oncology (London, England), 2014-10, Vol.10 (12), p.1967-1980

2014

Volltextzugriff (PDF)

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

Clinical & translational oncology, 2015-11, Vol.17 (11), p.862-869

2015

Volltextzugriff (PDF)

Prognostic value of the quantitative measurement of the oncoprotein p185Her‐2/neu in a group of patients with breast cancer and positive node involvement

International journal of cancer, 2002-10, Vol.101 (6), p.539-544

2002

Volltextzugriff (PDF)

Intensive Therapy for Aggressive Lymphoma

The New England journal of medicine, 2004-07, Vol.351 (1), p.98-100

2004

Volltextzugriff (PDF)

Central nervous system listeriosis confused with leptomeningeal carcinomatosis in cancer patients

American journal of clinical oncology, 2004-04, Vol.27 (2), p.211-212

2004

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Berichte
(3)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(16)
Oncology
(12)
Female
(10)
Middle Aged
(10)
Aged
(7)
Male
(7)
Retrospective Studies
(7)
Adult
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Breast Cancer
(5)
Treatment Outcome
(5)
Cyclophosphamide - Administration & Dosage
(4)
Aged, 80 And Over
(3)
Breast Neoplasms - Drug Therapy
(3)
Follow-Up Studies
(3)
Inflammation
(3)
Rituximab
(3)
Adenocarcinoma - Drug Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Information needs and research priorities in long‐term survivorship of breast cancer: Patients and health professionals' perspectives

2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

Hypoglycemic Coma Secondary to Big Insulin‐like Growth Factor II Secretion by a Giant Phyllodes Tumor of the Breast

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone

Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma

Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer

Soft tissue sarcomas: A challenge for oncology

Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene ( EGFR ) mutation testing

Predictive serum biomarkers in metastatic colorectal cancer (mCRC) patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (BVZ) (GEMCAD 09-01)

Some unusual paraneoplastic syndromes. Case 1. Metastatic squamous cell esophageal cancer to the thumb

Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601)

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

False Elevation of Serum CA 15-3 Levels in Patients Under Follow-Up for Breast Cancer

Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors

Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

Intensive Therapy for Aggressive Lymphoma/DR. MILPIED REPLIES

Therapeutic approaches in patients with newly diagnosed follicular lymphoma

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

Prognostic value of the quantitative measurement of the oncoprotein p185Her‐2/neu in a group of patients with breast cancer and positive node involvement

Intensive Therapy for Aggressive Lymphoma

Central nervous system listeriosis confused with leptomeningeal carcinomatosis in cancer patients

Aktive Filter

Suchergebnisse filtern